BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31274121)

  • 1. [Functional changes during the voiding phase in males with non-neurogenic detrusor underactivity undergoing bladder catheterization.].
    Vírseda-Chamorro M; Salinas-Casado J; Méndez-Rubio S; Barroso Manso Á; Esteban-Fuertes M
    Arch Esp Urol; 2019 Jul; 72(6):564-569. PubMed ID: 31274121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of clean intermittent catheterization in the treatment for detrusor underactivity.
    Méndez-Rubio S; López-Pérez E; Laso-Martín S; Vírseda-Chamorro M; Salinas-Casado J; Esteban-Fuertes M; Moreno-Sierra J
    Actas Urol Esp (Engl Ed); 2020 May; 44(4):233-238. PubMed ID: 32151472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous voiding is surprisingly recoverable via outlet procedure in men with underactive bladder and documented detrusor underactivity on urodynamics.
    Dobberfuhl AD; Chen A; Alkaram AF; De EJB
    Neurourol Urodyn; 2019 Nov; 38(8):2224-2232. PubMed ID: 31432550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two types of detrusor underactivity in men with nonneurogenic lower urinary tract symptoms.
    Matsukawa Y; Naito Y; Ishida S; Matsuo K; Majima T; Gotoh M
    Neurourol Urodyn; 2023 Jan; 42(1):73-79. PubMed ID: 36125443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tadalafil versus silodosin on voiding function in male patients with non-neurogenic detrusor underactivity: A comparative study using propensity score matching.
    Matsukawa Y; Majima T; Funahashi Y; Fujita T; Ishida S; Kato M; Gotoh M
    Int J Urol; 2021 Apr; 28(4):411-416. PubMed ID: 33393153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non-neurogenic lower urinary tract symptoms.
    Matsukawa Y; Yoshida M; Yamaguchi O; Takai S; Majima T; Funahashi Y; Yono M; Sekido N; Gotoh M
    Int J Urol; 2020 Jan; 27(1):47-52. PubMed ID: 31542892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men - A comparison of men with normal tracing and bladder outlet obstruction.
    Jiang YH; Kuo HC
    PLoS One; 2017; 12(4):e0174593. PubMed ID: 28376105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges in the diagnosis of detrusor underactivity in clinical practice: A mini-review.
    Ahmed A; Farhan B; Vernez S; Ghoniem GM
    Arab J Urol; 2016 Sep; 14(3):223-7. PubMed ID: 27547465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel clinical diagnostic criteria based on noninvasive examination findings to predict the presence of urodynamic detrusor underactivity in men.
    Matsukawa Y; Majima T; Mori A; Kamizyo S; Naito Y; Matsuo K; Ishida S; Gotoh M; Akamatsu S
    Neurourol Urodyn; 2024 Mar; 43(3):703-710. PubMed ID: 38299433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamics of men with urinary retention.
    Guo DP; Comiter CV; Elliott CS
    Int J Urol; 2017 Sep; 24(9):703-707. PubMed ID: 28687026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling detrusor underactivity: Development of a bladder outlet resistance-Bladder contractility nomogram for adult male patients with lower urinary tract symptoms.
    Oelke M; Rademakers KL; van Koeveringe GA;
    Neurourol Urodyn; 2016 Nov; 35(8):980-986. PubMed ID: 26235823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis.
    Osman NI; Chapple CR; Abrams P; Dmochowski R; Haab F; Nitti V; Koelbl H; van Kerrebroeck P; Wein AJ
    Eur Urol; 2014 Feb; 65(2):389-98. PubMed ID: 24184024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin can be a good predictor of urodynamic detrusor underactivity: a prospective study in men with lower urinary tract symptoms.
    Ishikawa T; Matsukawa Y; Naito Y; Ishida S; Majima T; Gotoh M
    World J Urol; 2023 Apr; 41(4):1117-1124. PubMed ID: 36823359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous adipose-derived mesenchymal stem cell therapy reverses detrusor underactivity: open clinical trial.
    Coelho HRS; Neves SCD; da Silva Menezes JN; Antoniolli-Silva ACMB; Oliveira RJ
    Stem Cell Res Ther; 2023 Apr; 14(1):64. PubMed ID: 37016455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ATOMS implant on the voiding phase of patients with post-prostatectomy urinary incontinence.
    Ruiz S; Virseda-Chamorro M; Salinas J; Queissert F; Arance I; Angulo JC
    Neurourol Urodyn; 2022 Feb; 41(2):609-615. PubMed ID: 34969148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detrusor underactivity versus bladder outlet obstruction clinical and urodynamic factors.
    Kalil J; D Ancona CAL
    Int Braz J Urol; 2020; 46(3):419-424. PubMed ID: 32167707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bladder outlet procedures on urodynamic assessments in men with an acontractile or underactive detrusor: A systematic review and meta-analysis.
    van Merode NAM; Nijholt IM; Heesakkers JP; van Koeveringe GA; Steffens MG; Witte LPW
    Neurourol Urodyn; 2023 Nov; 42(8):1822-1838. PubMed ID: 37498009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
    Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
    Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of detrusor underactivity in elderly men without neurological disorders.
    Kiba K; Akashi Y; Yamamoto Y; Hirayama A; Fujimoto K; Uemura H
    Low Urin Tract Symptoms; 2022 May; 14(3):193-198. PubMed ID: 35092360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction.
    Nitti VW; Rosenberg S; Mitcheson DH; He W; Fakhoury A; Martin NE
    J Urol; 2013 Oct; 190(4):1320-7. PubMed ID: 23727415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.